# YD Bio Ltd (YDES)

> Source: Nexqual · https://nexqual.com/YDES · data as of 2026-10-15 20:00 UTC · cite as "Nexqual, YD Bio Ltd (YDES), nexqual.com/YDES" · informational, not investment advice.

**Price:** USD 6.74 (+5.97% on the day) · last close of Oct 15, 2026; US market closed, not a live price. Prev close 6.36 · day 6.31–6.87 · 52w 1.7–22 · market cap $477M · NGM

## Key facts
- Analysts: None.
- Total return with dividends: 1Y -64.3% vs S&P 500 +18.1%; 5Y -46.1% vs S&P 500 +85.1%.

## Analysts
Consensus None.

## Total return (dividends reinvested)
|  | 1Y (from 2025-10-16) | 5Y (from 2025-08-25) |
|---|---|---|
| Total return | -64.3% | -46.1% |
| S&P 500 (SPY) | +18.1% | +85.1% |
| Per year | -64.4% | -41.8% |
| Volatility (annualized) | 129.2% | 151.9% |
| Max drawdown | -90.5% (Oct 2025→Jul 2026) | -91.8% (Sep 2025→Jun 2026) |

## Peers (Biotechnology)
RYTM (Rhythm Pharmaceuticals, Inc.) USD 87.97 +1.57% · BLTE (Belite Bio, Inc) USD 152.62 +0.49% · IOVA (Iovance Biotherapeutics, Inc.) USD 14.72 +1.52% · PRAX (Praxis Precision Medicines, Inc) USD 248.24 +2.01% · IONS (Ionis Pharmaceuticals, Inc.) USD 44.12 +4.11% · SYRE (Spyre Therapeutics, Inc.) USD 80.1 -0.44%

## More
Full page: https://nexqual.com/YDES · Free keyless MCP server with the same data and citations: https://mcp.nexqual.com/mcp · Guide for agents: https://nexqual.com/agents · https://nexqual.com/llms.txt